Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Auld

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal - Oklahoma Dental Association|November 28, 2013
What are the ethical implications on having more than one fee schedule?Douglas Auld
Journal of the American Dental Association (1939)|May 2, 2013
What are the ethical implications of having more than one fee schedule?Douglas Auld
Journal of the American Dental Association (1939)|February 28, 2016
You want me to do what?Douglas Auld
Idrugs : the Investigational Drugs Journal|December 3, 2003
Signal Transduction Therapeutics--SMi conference. 2-3 October 2002, The Hatton, London, UKDouglas Auld
Journal of the American Dental Association (1939)|March 31, 2015
Your mobile dental homeDouglas Auld
Assay and Drug Development Technologies|September 1, 2010
Improving success by balanced critical evaluations of assay methodsJames Inglese, Andrew Napper, Douglas Auld
SLAS Technology|June 11, 2026
Miniaturization of a Lumit p-ERK Immunoassay for Cell-Based High-Throughput Screening of a Chemogenetic Small-Molecule LibraryMatthew Swiatnicki, Hyun-Hee Cho, Douglas Auld, et al.
STAR Protocols|November 1, 2021
Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assayAnthony C Varca, Dominick Casalena, Douglas Auld, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2019
Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screeningAyse Okesli-Armlovich, Amita Gupta, Marta Jimenez, et al.
Assay and Drug Development Technologies|December 24, 2011
A sensitive, homogeneous, and high-throughput assay for lysine-specific histone demethylases at the H3K4 siteChunhua Wang, Mireille Caron, Debra Burdick, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal - Oklahoma Dental Association|November 28, 2013
What are the ethical implications on having more than one fee schedule?Douglas Auld
Journal of the American Dental Association (1939)|May 2, 2013
What are the ethical implications of having more than one fee schedule?Douglas Auld
Journal of the American Dental Association (1939)|February 28, 2016
You want me to do what?Douglas Auld
Idrugs : the Investigational Drugs Journal|December 3, 2003
Signal Transduction Therapeutics--SMi conference. 2-3 October 2002, The Hatton, London, UKDouglas Auld
Journal of the American Dental Association (1939)|March 31, 2015
Your mobile dental homeDouglas Auld
Assay and Drug Development Technologies|September 1, 2010
Improving success by balanced critical evaluations of assay methodsJames Inglese, Andrew Napper, Douglas Auld
SLAS Technology|June 11, 2026
Miniaturization of a Lumit p-ERK Immunoassay for Cell-Based High-Throughput Screening of a Chemogenetic Small-Molecule LibraryMatthew Swiatnicki, Hyun-Hee Cho, Douglas Auld, et al.
STAR Protocols|November 1, 2021
Identification of deubiquitinase inhibitors via high-throughput screening using a fluorogenic ubiquitin-rhodamine assayAnthony C Varca, Dominick Casalena, Douglas Auld, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2019
Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screeningAyse Okesli-Armlovich, Amita Gupta, Marta Jimenez, et al.
Assay and Drug Development Technologies|December 24, 2011
A sensitive, homogeneous, and high-throughput assay for lysine-specific histone demethylases at the H3K4 siteChunhua Wang, Mireille Caron, Debra Burdick, et al.
Pageof 3